Skip to main content
. 2021 Jan 21;91(1-2):22–26. doi: 10.1111/ans.16464

Table 1.

Patient demographics and perioperative characteristics (n = 4965)

Factor Missing n (%)
Mean (SD) age, years 47.0 (25.1) 0
Range 0–99
Sex
Female 2349 (47.3) 0
Male 2616 (52.7)
ASA physical status
1 986 (19.9) 0
2 2217 (44.7)
3 1579 (31.8)
4 183 (3.7)
Ethnicity 283 (6.0)
White 3263 (69.7)
Asian 441 (9.4)
ATSI 25 (0.5)
Black/African 50 (1.1)
Other 903 (19.3)
Socio‐economic classification (IRSAD) 23 (0.5)
1–20% 604 (12.2)
21–40% 763 (15.4)
41–60% 915 (18.5)
61–80% 1072 (21.7)
81–100% 1588 (32.1)
Comorbidities
CVD (including HT, HF, CAD) 1766 (35.6) 2 (0.0)
Treated diabetes 642 (12.9) 2 (0.0)
COPD and/or asthma 771 (15.5) 2 (0.0)
Month of surgery 5 (0.1)
July 1302 (26.3)
August 3658 (73.8)
Preoperative screening on admission 4618 (93.3) 14 (0.3)
Temperature check on admission 4861 (98.0) 4 (0.1)
Overseas travel in 2020 27 (0.6) 623 (14.3)
When was travel 5 (19) 0
≤2 weeks 22 (81)
>2 weeks
COVID‐19 contact 13 (0.3) 16 (0.3)
When was contact 0
≤2 weeks 9 (69)
>2 weeks 4 (31)
Health worker 136 (2.7) 3 (0.1)
Surgery type 3 (0.1)
Orthopaedic 381 (7.7)
Urology 697 (14.0)
Gynaecological 361 (7.3)
Gastrointestinal 536 (10.8)
Plastics 415 (8.4)
Neurological 155 (3.1)
Cardiac 201 (4.1)
Vascular 127 (2.6)
Ear, nose, throat 286 (5.8)
Endoscopy 952 (19.2)
Ophthalmology 59 (1.2)
Oral/faciomaxillary 61 (1.2)
Other 731 (14.7)
Unplanned ICU/HDU admission 36(0.07) 32 (0.6)
Hospital stay 7 (0.1)
≥1 night stay 2112 (42.6)
Day case 2846 (57.4)
Number of nights in hospital, median (IQR) 2.0 (1.0. 5.0) 34 (1.6)
In‐hospital mortality 10 (0.2) 37 (0.8)

Data are represented as number (%), unless otherwise indicated.

Patients still as inpatients on 22 September 2020.

ASA, American Society of Anesthesiologists; ATSI, Aboriginal or Torres Strait Islander; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HDU, high‐dependency unit; HF, heart failure; HT, hypertension; ICU, intensive care unit; IQR, interquartile range; IRSAD, Index of Relative Socio‐economic Advantage and Disadvantage.